InteRNA Technologies

About:

InteRNA Technologies provides drug discovery and development services.

Website: https://interna-technologies.com/

Top Investors: Alumni Ventures, Inkef, OostNL, Aglaia BioMedical Ventures, Aurora Science

Description:

InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment Nijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors participating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels.

Total Funding Amount:

$37.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)interna-technologies.com

Founders:

Roel Schaapveld

Number of Employees:

11-50

Last Funding Date:

2021-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai